Qian Chun, Minister of the Academic Department of Guangdong Association for Science and Technology, and Zeng Musheng, Vice President of Sun Yat-sen University Cancer Hospital attended the meeting and delivered congratulatory speeches. Professor Xia Jianchuan, chairman of the conference, chairman of the Guangdong Society of Cell Biology, and chairman of the Biotherapy Professional Committee of the Guangdong Anti-Cancer Association, delivered an opening speech. Professor Chen Zunqi, honorary chairman of the Guangdong Society of Cell Biology, and Professor Ge Yueping, consultant of the Guangdong Society of Cell Biology, attended the meeting to express congratulations.

This academic annual meeting is not only the fruit of the Guangdong Society of Cytology and the Biotherapy Committee of the Guangdong Anti-Cancer Association in the past year, but also a high-level breakthrough in the next step. From basic research to clinical application, from stem cell to T cell clinical application, targeted therapy of lung cancer, and talked about precision medicine and precision tumor treatment, the content is wide and the research is deep.

ACTL targeted anti-tumor cell immune technology is an advanced, effective and targeted individualized anti-tumor biotherapy technology. Through advanced biotechnology, the patient’s immune cells (CD8 positive T cells) are activated in vitro After being reinfused into the patient's body, these activated T cells can accurately find tumor cells and launch attacks, which is deeply in line with the concept of precision medicine.

This academic annual meeting was held at the time when the country vigorously promoted precision medicine, cell biology, tumor immunology and clinical applications. It gathered leaders in cytology and oncology in the province, and focused on "basic research in cell biology, Somatic cell anti-tumor immunity, clinical application research" and other topics, carry out academic seminars, share new technologies and research results in the field of cell research over the past year, promote the promotion, application, popularization and prosperity of cell biology and biotherapeutics, and promote cell biology The rapid development of the field of science has provided more and better biological treatment methods for the rehabilitation of tumor patients.

Yishi Kangning will also, under the leadership of the Guangdong Cell Society and the Biotherapy Committee of the Guangdong Anti-Cancer Association, repay the society with innovative technology!